首页 | 本学科首页   官方微博 | 高级检索  
     

咪喹莫特乳膏治疗尖锐湿疣随机、双盲、多中心研究
引用本文:顾恒,曾凡钦,郭在培,彭振辉,毕志刚,朱学骏,陈昆,郭庆,张谊之,闫乎铃,张美华,韩钢文,常宝珠,刘训荃,王家璧. 咪喹莫特乳膏治疗尖锐湿疣随机、双盲、多中心研究[J]. 中华皮肤科杂志, 2003, 36(9): 501-504
作者姓名:顾恒  曾凡钦  郭在培  彭振辉  毕志刚  朱学骏  陈昆  郭庆  张谊之  闫乎铃  张美华  韩钢文  常宝珠  刘训荃  王家璧
作者单位:1. 中国医学科学院、中国协和医科大学皮肤病研究所, 南京210042;2. 中山大学第二医院;3. 四川大学华西医院;4. 西安交通大学第二医院;5. 南京医科大学第一附属医院;6. 北京大学第一医院;7. 中国医科大学附属第一医院皮肤科
摘    要:目的 了解5%咪喹莫特乳膏治疗肛周和外生殖器尖锐湿疣的临床疗效和安全性。方法 采用随机、双盲、平行对照的临床研究方法,受试者每周3次外搽研究药物,疗程8周。疣体完全消退者继续随访1月以观察复发率。结果 共有258例肛周及外生殖器尖锐湿疣患者参加本次研究,其中5%咪喹莫特乳膏治疗组129例,安慰剂对照组129例。治疗后2、4、6、8周的痊愈率在治疗组分别为12.30%、32.79%、50%及60.66%,对照组分别为4.88%、14.63%、19.51%及26.02%,两组间差异有非常显著性(P<0.001);疗后2、4、6、8周的有效率在治疗组分别为36.89%、59.84%、68.03%及70.49%,对照组分别为13.82%、26.83%、32.52%及32.52%,两组间差异有非常显著性(P<0.001)。治疗组74例痊愈患者经随访1月后有4例复发,复发率为5.41%,与对照组相比差异无显著性。治疗组给药部位局部不良反应包括:红斑60.94%、水肿31.26%、糜烂42.96%、溃疡4.68%、灼热20.32%、疼痛36.72%、瘙痒17.18%。无系统不良反应。结论 5%咪喹莫特乳膏治疗肛周和外生殖器尖锐湿疣疗效好,安全性好,使用方便。

关 键 词:尖锐湿疣  投药  皮肤  咪喹莫特  
收稿时间:2003-04-01
修稿时间:2003-04-01

Treatment of Condyloma Acuminatum with Imiquimod Cream: A Randomized, Double-blind, Placebo-controlled, Multi-central Clinical Trial
GU Heng ,ZENG Fan-qin,GUO Zai-pei,PENG Zhen-hui,BI Zhi-gang,ZHU Xue-jun,CHEN Kun,GUO Qing,ZHANG Yi-zhi,YAN Hu-ling,ZHANG Mei-hua,HAN Gang-wen,CHANG Bao-zhu,LIU Xun-quan,WANG Jia-bi. Treatment of Condyloma Acuminatum with Imiquimod Cream: A Randomized, Double-blind, Placebo-controlled, Multi-central Clinical Trial[J]. Chinese Journal of Dermatology, 2003, 36(9): 501-504
Authors:GU Heng   ZENG Fan-qin  GUO Zai-pei  PENG Zhen-hui  BI Zhi-gang  ZHU Xue-jun  CHEN Kun  GUO Qing  ZHANG Yi-zhi  YAN Hu-ling  ZHANG Mei-hua  HAN Gang-wen  CHANG Bao-zhu  LIU Xun-quan  WANG Jia-bi
Affiliation:Institute of Dermatology, Chinese Academy of Medical Sciences&Peking Union Medical College, Nanjing 210042, China
Abstract:Objective To observe the clinical efficacy and safety of5%imiquimod cream in the top-ical treatment of condyloma acuminatum(CA).Methods A randomized,double-blind,parallel placebo-controlled clinical study was conducted.The test drug was topically used in CA patients,three times a week for8weeks.Patients whose warts cleared completely were followed up for one month to determine recurrence rates.Results Two hundred fifty-eight patients with anogenital warts were enrolled into this trial.One hun-dred twenty-nine patients were randomly selected to receive5%imiquimod cream;129patients were ran-domly chosen to receive placebo cream.Results showed that the cure rates were12.30%,32.79%,50%,60.66%respectively in study group for2,4,6,8weeks and were4.88%,14.63%,19.51%,26.02%respec-tively in control group for2,4,6,8weeks(P<0.001).The response rates were36.89%,59.84%,68.03%,70.49%respectively in study group for2,4,6,8weeks and13.82%,26.83%,32.52%,32.52%respec-tively in control group for2,4,6,8weeks(P<0.001).Of imiquimod-treated patients whose warts cleared completely and who finished one month follow-up period,5.41%(4of74)experienced recurrences of warts.Side effect included erythema(60.94%),edema(31.26%),erosion(42.96%),ulceration(4.68%),burning(20.32%),pain(36.72%),itching(17.18%).There was no systemic side effect in two groups.Conclusion5%Imiquimod cream in the topical treatment of anogenital warts is effective,safe and convenient.
Keywords:Condylomata acuminata  Administration  cutaneous  Imiquimod
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中华皮肤科杂志》浏览原始摘要信息
点击此处可从《中华皮肤科杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号